way forward for the total CB defense program and defines a fully coordinated and integrated investment strategy strongly supported throughout the Department of Defense. Our goal is to ensure full dimensional protection for all our Servicemen and women operating under the threat of continued proliferation of weapons of mass destruction. Development of effective capabilities to counter the threat is vital to ensuring full dimensional protection of U.S. Forces in a contaminated environment. Our investments therefore must be selective, focusing on the threats and opportunities most relevant to our requirements and applying our resources where we can make the greatest difference. The Joint Service Materiel Group (JSMG) has developed a coordinated Research, Development, and Acquisition (RDA) plan that supports the seamless integration of technologies into a system-of-systems architecture for integration across the spectrum of combat and support systems. This plan reveals the Joint Services' strategy for reducing Chemical and Biological (CB) defensive capability shortfalls in the midterm while modernizing to meet far-term Joint Future Operational Capabilities (JFOCs). This plan illustrates a comprehensive business strategy of how the Military Departments will build the CB Defense Program (CBDP) to meet Commander-In-Chief (CINC) and warfighter requirements and provides an overall assessment on the fiscal and technological outlook for the period FY03-17. The CB Defense programs are categorized broadly under six operationally oriented commodity areas: contamination avoidance, individual protection, collective protection, decontamination, medical sys@[ÌÌÌÌÍÿ¾Û€  (less)

the DoD CBDP. This section summarizes the key counterproliferation priorities and the current CB warfare threats to U.S. forces. Intelligence documents tailored to the threat are essential for developing and updating requirements for CB defense programs. Each CB defense research, development, and acquisition effort funded within the program responds to a defined or validated threat. Variations among chemical and biological agents and each agents unique physical, toxicological, destructive, and other properties such as means of delivery require a capabilities based response. Intelligence efforts continue to emphasize collection and analysis of nations dual-use chemical and biological industrial capabilities and develop the indications and warning of adversarial use or diversion of dual-use capabilities to weapons programs. PChapter 1 describes the accomplishments, processes, and issues related to program management and oversight. This chapter provides an overview of the re-organization of the CBDP management structure that was initiated in 2002 and is being implemented during 2003. Chapter 2 provides information on medical and non-medical CB defense requirements and research, development, and acquisition programs. This chapter outlines plans and strategies for the development and acquisition of capabilities in each of the program commodity areas, including contamination avoidance, individual protection, collective protection, modeling and simulation, medical chemical defense, and medical biological defense. In addition, this chapter includes a Special Report on Anthrax Vaccine Costs, Acquisition Strategy, and Related Issues. Research, development, and acquisiti@[ÌÌÌÌÍÿ¾Û€  (less)

Technology Base: Research and Development; Intelligence and Surveillance; Medical Countermeasures; Physical Countermeasures; Forensics; Proactive Deterrence; Public Health Infrastructure; Interagency Collaboration; Education; Complementary programs; International Cooperation; New Technologies PCentral to the recommendations are the following: (1) we must prepare for hundreds to thousands of casualties; even if the current probability of attack is low, it will certainly increase with the dissemination of scientific advances, possibly to the point of empowering of the individual terrorist; (2) there must be a concerted effort and investment with strong leadership to improve preparations in the years ahead; and (3) most investments and new technology applications will have a beneficial dual use - for our public health structure and for our society. P* Terrorism, the Future, and U.S. Foreign Policy * National Commission on Terrorism Report Background * United States Response to Terrorism * Response to Bombings in Kenya and Tanzania * Terrorist Attack on USS Cole Background * Operational Plans * Challenges in Coordinating the Response to Bioterrorism * State Emergency Response Plans for Biological Terrorism * Military and Law Enforcement Terrorism Counteraction Model * Terrorism Incident Annex * Assessment of Biological Weapons Threat to the U.S. * Averting the Hostile Exploitation of Biotechnology * Response to Weapons of Mass Destruction * Deterring CBRN Terrorism (Chemical, Biological, Radiological, Nuclear) * Robots * The Hanover Virus of 2005  A Fictional Scenario  (less)